| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $614.4M | +26.2% |
| R&D Expense | $44.6M | +30.0% |
| SG&A Expense | $249.6M | +54.4% |
| Operating Income | $584K | -98.8% |
| Interest Expense | $33.6M | +3.6% |
| Pre-tax Income | -$22.2M | -211.8% |
| Income Tax | -$3.7M | -437.6% |
| Net Income | -$18.5M | -198.6% |
| EPS (Basic) | -$1.04 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $144.9M | -34.5% |
| Accounts Receivable | $221.7M | +36.8% |
| Inventory | $136.8M | +23.0% |
| Current Assets | $527.7M | +1.5% |
| Total Assets | $1.28B | +41.9% |
| Current Liabilities | $193.7M | +33.1% |
| Long-term Debt | $309.1M | +8.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $64.0M | -46.2% |
| Capital Expenditures | $16.2M | +83.1% |
| Investing Cash Flow | -$404.7M | -2086.4% |
| Financing Cash Flow | $264.9M | +292.9% |
| Free Cash Flow | $47.8M | -56.6% |
| -220.9% |
| EPS (Diluted) | -$1.04 | -222.4% |
| Total Liabilities |
| $855.2M |
| +91.4% |
| Stockholders' Equity | $403.7M | -6.7% |